Stock Events

Stock Events

Ovid Therapeutics (1OT.F) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.21

-0.1

0

0.11

Details

Expected EPS

-0.19453999154999999

Actual EPS

-0.18839

Surprise EPS

0.01

Surprise Percent

+3.16%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.18839 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.